7:07 am Prana Biotech announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer’s disease; PBT2 did not meet its primary endpoint of a statistically significant reduction in the levels of beta-amyloid plaques in the brains
View todays social media effects on PRAN
View the latest stocks trending across Twitter. Click to view dashboard
See who Prana is hiring next, click here to view
